Global Intrapartum Monitoring Devices Market Size, Share, Opportunities, And Trends By Type (Electrodes, Monitors), By Method (Invasive, Non-Invasive), By End-User (Hospitals, Maternity Specialty Hospitals), And By Geography - Forecasts From 2025 To 2030

The global intrapartum monitoring devices market is predicted to expand at a CAGR of 5.79% to account for US$2,893.453 million by 2030 from US$2,183.757 million in 2025.

The lack of access to appropriate maternal care facilities and disparities of income in different regions lead to a difference in mortality rates across the world. Developing countries face greater challenges of infant mortality owing to the presence of lower-income groups, lack of infant care facilities, and unmet needs for obstetric care. The neonatal mortality rate in countries like South Africa is 11, while in China and the USA, this is as low as 3 and 3.2, respectively. These disparities in neonatal mortality exist across regions and countries.  

Innovative developments, for instance, such as in February 2024, Novii+ Wireless Maternal and Fatal Monitoring Solution received FDA clearance for providing patient comfort and mobility in the hospital, increasing demand for maternity care devices over the forecast period. Further, the application of AI in monitoring devices, such as Perigean in August 2023, introduced a clinical escalation management tool for the intrapartum Chain of Command, CloudWatch. The CloudWatch is powered by Per iWatch Vigilance, an AI-based maternal-foetal early warning system in the United States. 

 What are the drivers of the global intrapartum monitoring devices market?

• Growing birth rates in certain developing countries

Although the birth rate worldwide has been decreasing in the last few decades, the disparities among regions and the world are huge. For example, the birth rate in Saudi Arabia is estimated to be 13.6 in 2024, but in Iraq, it is as high as 23.7.

The United States have a birth rate of 12.2 in 2024, but countries like India have a birth rate of 16.2, and China has 10.2. These birth rate disparities in the countries give growth opportunities for intrapartum monitoring devices in their markets. Additionally, the growing awareness about labour care and maternal care is increasing the popularity of these products.

• The hospital segment is expected to grow substantially in the market.

Intrapartum monitoring devices are important tools used in obstetric treatment. They are commonly used in hospitals to monitor foetal heart rate or the increase in uterine contractions during labour. These devices help clinicians prevent possible risks like preterm labour or foetal trouble by providing information on the status of the mother and the foetus.

Furthermore, the American Hospital Association stated that the United States has 6,120 hospitals as of 2024, which further affects the market growth. During labour and delivery in hospitals, intrapartum monitoring devices are crucial to the mother's and the foetus’s safety and well-being.

 Additionally, the Saudi Arabian government intends to invest more than $65 billion under Vision 2030 to build the nation's healthcare infrastructure, restructure and privatize insurance and health services, establish "health clusters" nationwide, and increase the availability of e-health services. Similarly, increased private sector participation is aimed to be increased from 40 % to 65 % by 2030. This would entail the privatization of 290 hospitals and 2300 primary health centres, thus creating considerable business opportunities for American companies investing in Saudi Arabia’s expanding healthcare market.

As per the International Trade Administration, US$161 billion was spent on healthcare in Brazil, representing 9.47% of GDP. Brazil holds the leading position in the healthcare market of Latin America. As of 2023, of the 7191 hospitals, 62% are privately owned in the nation, as shown by the data of the Brazilian Federation of Hospitals (FBH) and the National Healthcare Association (Naude).

 In addition, in Argentina, about 35% of the population depended on public hospitals in 2022. The remaining individuals are covered in some capacity by social security or union-run healthcare (60% of the population) or by the private healthcare system (13%).

Comprehensively, the increased health awareness amongst patients, a higher literacy rate, and the increasing number of hospitals, especially in developing countries, which require more intrapartum monitoring services, are driving the market. Intrapartum monitoring devices will remain an essential aspect of obstetrics as healthcare systems evolve and institutionalize care for mother and foetus.

Geographical outlooks of the global intrapartum monitoring devices market:

• Asia Pacific to hold significant shares of the global intrapartum monitoring devices market.

The major economies like China, Japan, India, and South Korea lead the Asia-Pacific region. Some of the fastest-growing emerging economies, such as ASEAN countries, are from this region.

In China, the intrapartum monitoring devices market will witness significant growth owing to several important factors, such as the increasing birth rate and population, which is known to be the primary catalyst, necessitating effective monitoring solutions during labour. With China’s increasing population, the number of pregnancies is also growing, requiring the efficient need for advanced medical technologies that could ensure the safety and health of both the mother and infant during childbirth. Furthermore, in 2022, the Chinese government came up with measures to improve the pre- and post-natal services, which could encourage more people to have children. It reiterated its intent to discourage abortions as it seeks to turn around the declining birth rate.

According to the Pew Research Centre, as per the UN estimates, China had the highest population rate at 1.426 billion in 2022, which is larger than the entire population of Europe (744 million) and the Americas (1.04 billion). However, it's roughly equivalent to the population of all the nations in Africa (1.427 billion). This population growth will result in the increasing pregnancies directly correlating with the intrapartum monitoring devices market’s expansion.

Technological advancements also play a crucial role in this market's growth. The development of non-invasive and portable monitoring devices has improved accessibility and convenience for healthcare providers and patients alike. Furthermore, government initiatives, as mentioned above, are also playing a role in driving market growth.

Company profiling in the global intrapartum monitoring devices market:

• Mind Child Medical developed MERIDIAN M110, a non-invasive foetal and maternal monitoring technology that displays foetal and maternal heart rates. 
• Coro metrics 250cx Series Maternal/Fatal Monitor by GE Healthcare is a full antepartum/intrapartum foetal monitor. It monitors uterine and foetal activity, including foetal heart rate, and maternal monitoring features, including temperature, oxygen saturation, ECG, and non-invasive blood pressure. 
• Melody International Ltd. offers a Wearable Fatal Monitor, act, a small and smart wireless foetal monitoring device. The system comprises a foetal heart monitor, a uterine contraction monitor, and a tablet.
• Cardinal Health, headquartered in Dublin, is imperative as it offers a range of products and services, including patient monitoring and supply chain management solutions. The company provides customized solutions for healthcare systems, hospitals, ambulatory surgery centres, pharmacies, clinical laboratories, and many more. In the intrapartum monitoring devices market, Cardinal Health offers a full line of recording charts for antepartum through their Kendall Fatal Paper that could fit monitors from major manufacturers, including Philips, GE Medical, Oxford, Spacelabs, and others.

Key developments in the global intrapartum monitoring devices market:

• In 2024, announced that the company has completed the separation of GE Healthcare and has launched GE HealthCare Technologies Inc. 
• In 2024, GE Healthcare partnered with biovolumes to extend patient monitoring outside the hospital with virtual care-at-home solutions.

Intrapartum Monitoring Devices Market Scope:

Report Metric	Details
Intrapartum Monitoring Devices Market Size in 2025	US$2,183.757 million
Intrapartum Monitoring Devices Market Size in 2030	US$2,893.453 million
Growth Rate	CAGR of 5.79%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Million
Segmentation	Type Method End-User Geography
Geographical Segmentation	North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in Intrapartum Monitoring Devices Market	Mindchild Medical, Inc. GE Healthcare (General Electric Company) Koninklijke Philips N.V. Neoventa Medical AB Anjue Medical Equipment Co., Ltd.
Customization Scope	Free report customization with purchase

Market Segmentation:

The Global intrapartum monitoring devices market is segmented and analysed as below:

• By Type
  • Electrodes
  • Electronic Monitors
• By Method
  • Invasive
  • Non-Invasive
• By End-User
  • Hospitals
  • Home Births
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others

---

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

2.1. Research Design

2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Key Findings

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View

5. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET BY  TYPE

5.1. Introduction

5.2. Electrodes

5.3. Electronic Monitors 

6. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET BY METHOD

6.1. Introduction

6.2. Invasive

6.3. Non-Invasive

7. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET BY END-USER

7.1. Introduction

7.2. Hospitals 

7.3. Home Births

8. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. By Type

8.2.2. By Method

8.2.3. By End-User

8.2.4. By Country

8.2.4.1. USA

8.2.4.2. Canada

8.2.4.3. Mexico

8.3. South America

8.3.1. By Type

8.3.2. By Method

8.3.3. By End-User

8.3.4. By Country

8.3.4.1. Brazil

8.3.4.2. Argentina

8.3.4.3. Others

8.4. Europe

8.4.1. By Type

8.4.2. By Method

8.4.3. By End-User

8.4.4. By Country

8.4.4.1. United Kingdom

8.4.4.2. Germany

8.4.4.3. France

8.4.4.4. Italy

8.4.4.5. Spain

8.4.4.6. Others

8.5. Middle East and Africa

8.5.1. By Type

8.5.2. By Method

8.5.3. By End-User

8.5.4. By Country

8.5.4.1. Saudi Arabia

8.5.4.2. UAE

8.5.4.3. Others

8.6. Asia Pacific

8.6.1. By Type

8.6.2. By Method

8.6.3. By End-User

8.6.4. By Country

8.6.4.1. China

8.6.4.2. Japan

8.6.4.3. India

8.6.4.4. South Korea

8.6.4.5. Australia

8.6.4.6. Indonesia

8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Mindchild Medical, Inc.

10.2. GE Healthcare (General Electric Company)

10.3. Koninklijke Philips N.V.

10.4. Neoventa Medical AB

10.5. Anjue Medical Equipment Co., Ltd.

10.6. Cardinal Health

10.7. CooperSurgical Inc.

10.8. BIRAC

10.9. Melody International Ltd.

Mindchild Medical, Inc.

GE Healthcare (General Electric Company)

Koninklijke Philips N.V.

Neoventa Medical AB

Anjue Medical Equipment Co., Ltd.

Cardinal Health

CooperSurgical Inc.

BIRAC

Melody International Ltd.